Table of Contents Table of Contents
Previous Page  56 / 104 Next Page
Information
Show Menu
Previous Page 56 / 104 Next Page
Page Background

54

NCCN Guidelines for Patients

®

:

Ovarian Cancer, Version 1.2017

5

Treatment guide

Stages II, III, and IV ovarian cancer

Guide 8

shows the options that are recommended

after surgery for stage II, III, or IV ovarian cancer.

Most women with ovarian cancer will receive

chemotherapy after primary treatment with surgery.

This is called adjuvant treatment. Your doctor may

also refer to this as primary chemotherapy.

There are a few adjuvant treatment options to

choose from. Which option is best for you depends

on the cancer stage and how much cancer is left

after surgery. The cancer stage is a rating of how

much the cancer has grown and spread. The goal

of surgery is to not leave behind any tumors that are

1 cm or larger.

Guide 8. Treatment after surgery for stages II, III, and IV ovarian cancer

Cancer stage

Adjuvant treatment options

Stage II or III

Cancer has spread to nearby

organs and tissues in the

pelvis, or it has spread to

tissues in the abdomen

Stage IV

Cancer has spread outside

the abdomen to organs and

tissues in other parts of the

body

ª

• Chemotherapy given in the abdomen (IP), or

• Chemotherapy given in a vein (IV) for a total of 6 cycles

• Completion surgery based on tumor response and possibility or

being able to remove the cancer (certain patients)

Chemotherapy regimens for stage II, III, and IV ovarian cancer

Chemotherapy regimens

Route given Length of a cycle

Paclitaxel and cisplatin

Injection in a vein (IV) and

abdomen (IP)

21 days (3 weeks)

Paclitaxel and carboplatin

Injection in a vein (IV) and

abdomen (IP)

21 days (3 weeks)

Dose-dense paclitaxel and carboplatin

Injection in a vein (IV)

21 days (3 weeks)

Paclitaxel and carboplatin

Injection in a vein (IV)

7 days (1 week)

Docetaxel and carboplatin

Injection in a vein (IV)

21 days (3 weeks)

Carboplatin and liposomal doxorubicin

Injection in vein (IV)

28 days (4 weeks)

Bevacizumab with paclitaxel and carboplatin Injection in a vein (IV)

21 days (3 weeks)